Evidence map›Paper›PMID 40822073›Full record

ArticleMedical journal, Armed Forces India2025

Multiple myeloma with an unusual presentation.

Sajitha K, Michelle Mathias

Abstract readCase Reports
In one paragraph

Article in Medical journal, Armed Forces India, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sajitha KAssociate Professor (Pathology), K S Hegde Medical Academy, Mangalore, Karnataka, India.
Michelle MathiasProfessor (Pathology), K S Hegde Medical Academy, Mangalore, Karnataka, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Central nervous system (CNS) involvement in multiple myeloma (MM) is rare and can be a challenge to diagnose due to the heterogenous symptoms and associated confounding neurological symptoms because of any other underlying condition. CNS - MM can occur either at the onset of the disease or during relapse when the myeloma is usually more aggressive and the patient would have already taken different types of treatments. CNS - MM has a grim prognosis inspite of the availability of newer modalities of pharmacologic treatment including immunomodulatory drugs and proteasome inhibitors. Here, we report a case of MM with CNS involvement at presentation which posed a diagnostic challenge. This case is being reported due to its rarity of occurrence and limited data available in literature.

Indexed as

Multiple myelomaPlasma cellsPlasmacytoma

Identifiers

PMID40822073
PMCPMC12351041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.